SAGE Therapeutics Inc. (SAGE) announced its expedited development plan for SAGE-547 Tuesday morning. The move was made after the company received formal meeting minutes from a breakthrough therapy meeting with the FDA.
from RTT - Before the Bell http://ift.tt/2hhP3Xx
via IFTTT
No comments:
Post a Comment